Search

Viral antigens are among the strongest elicitors of immune responses. A significant proportion of the human population already carries pre-existing immunity against several childhood viruses, which could potentially be leveraged to fight cancer. We sought to provide proof of concept in mouse models that a pre-existing measles virus (MeV) immunity can be redirected to inhibit tumor growth by directly forcing expression of cognate antigens in the tumor. To this end, we designed DNA vaccines against known MeV cytotoxic and helper T epitopes, and administered these intradermally to mice that were subsequently challenged with syngeneic squamous cancer cells engineered to either express the cognate antigens or not. Alternatively, established wild-type tumors in vaccinated animals were treated intratumorally with in vitro transcribed mRNA encoding the cognate epitopes. Vaccination generated MeV cytotoxic T lymphocyte (CTL) immunity in mice as demonstrated by enhanced interferon gamma production, antigen-specific T cell proliferation, and CTL-mediated specific killing of antigen-pulsed target cells. When challenged with syngeneic tumor cells engineered to express the cognate antigens, 77% of MeV-vaccinated mice rejected the tumor versus 21% in control cohorts. Antitumor responses were largely dependent on the presence of CD8+ cells. Significant protection was observed even when only 25% of the tumor bulk expressed cognate antigens. We therefore tested the strategy therapeutically, allowing tumors to develop in vaccinated mice before intratumoral injection with Viromer nanoparticles complexed with mRNA encoding the cognate antigens. Treatment significantly enhanced overall survival compared with controls, including complete tumor regression in 25% of mice. Our results indicate that redirecting pre-existing viral immunity to fight cancer is a viable alternative that could meaningfully complement current cancer immune therapies such as personalized cancer vaccines and checkpoint inhibitor blockade.

Background The Crabtree-negative yeast species Kluyveromyces lactis has been established as an attractive microbial expression system for recombinant proteins at industrial scale. Its LAC genes allow for utilization of the inexpensive sugar lactose as a sole source of carbon and energy. Lactose efficiently induces the LAC4 promoter, which can be used to drive regulated expression of heterologous genes. So far, strain manipulation of K. lactis by homologous recombination was hampered by the high rate of non-homologous end-joining. Results Selection for growth on lactose was applied to target the insertion of heterologous genes downstream of the LAC4 promoter into the K. lactis genome and found to yield high numbers of positive transformants. Concurrent reconstitution of the β-galactosidase gene indicated the desired integration event of the expression cassette, and β-galactosidase activity measurements were used to monitor gene expression for strain improvement and fermentation optimization. The system was particularly improved by usage of a cell lysis resistant strain, VAK367-D4, which allowed for protein accumulation in long-term fermentation. Further optimization was achieved by increased gene dosage of KlGAL4 encoding the activator of lactose and galactose metabolic genes that led to elevated transcription rates. Pilot experiments were performed with strains expressing a single-chain antibody fragment (scFvox) and a viral envelope protein (BVDV-E2), respectively. scFvox was shown to be secreted into the culture medium in an active, epitope-binding form indicating correct processing and protein folding; the E2 protein could be expressed intracellularly. Further data on the influence of protein toxicity on batch fermentation and potential post-transcriptional bottlenecks in protein accumulation were obtained. Conclusions A novel Kluyveromyces lactis host-vector system was developed that places heterologous genes under the control of the chromosomal LAC4 promoter and that allows monitoring of its transcription rates by β-galactosidase measurement. The procedure is rapid and efficient, and the resulting recombinant strains contain no foreign genes other than the gene of interest. The recombinant strains can be grown non-selectively in rich medium and stably maintained even when the gene product exerts protein toxicity.

Over the past two decades, oligonucleotide (ON)-based approaches to inhibit the expression of target genes using, e.g. antisense oligonucleotides (ASOs), small interfering RNAs (siRNAs), ribozymes, decoys, or aptamers have emerged as valuable tools for functional genomics, gene target validation, an...

A linear functional $J(f)$ defined on $C^{m - 1} [a,b]$ can be approximated by appropriate linear combinations of function values $f(x_i )$ at discrete points $x_1 , \cdots ,x_n \in [a,b]$. The problem of best approximation with respect to a given class of functions was posed by Sard [11] and solved for special classes by Schoenberg [12]. We give a simplified proof of Schoenberg’s result which immediately carries over to the periodic case. An example for its application is the attenuation factors in practical Fourier analysis. Another extension is possible if interpolation is replaced by smoothing.

Es wurden Neutronen mit Energien von 0,039 und 0,078 eV an dünnen Schichten von Wasser und Eis verschiedener Temperaturen gestreut. Die Winkelverteilung der Streuneutronen wurde durch einen Li6J-Szintillationszähler mit einer Nachweisempfindlichkeit von nahezu 100% bestimmt und hieraus der differentielle Streuquerschnitt σ(ϑ) berechnet. Es ergab sich nur ein geringer Unterschied zwischen Wasser und Eis; er rührt hauptsächlich vom Beitrag der kohärenten Streuung im Eis her, welcher im Wasser verschwindet. Ferner wurde aus Transmissionsversuchen mit Silberfolien die Änderung der mittleren Neutronenenergie bestimmt. Ein Vergleich mit der Theorie von NELKIN kann später durchgeführt werden.